Lesser M, Fung K, Choi H S, Yoo O H, Cardozo C
Department of Medicine, Bronx Veterans Affairs Hospital, NY 10468.
J Lab Clin Med. 1992 Oct;120(4):597-603.
Neutral endopeptidases EC 3.4.24.11 and EC 3.4.24.15, widely distributed zinc metalloendopeptidases, degrade a number of biologically active peptides including substance P, bradykinin, neurotensin, and luteinizing hormone-releasing hormone. In this study we measured EC 3.4.24.11 and EC 3.4.24.15 activity in alveolar macrophages, key inflammatory cells in the lung that produce and respond to a large number of bioactive substances including chemotactic peptides, with the substrates glutaryl-ala-ala-phe-2-naphthylamide and tertiary butoxycarbonyl-phe-ala-ala-phe-paraaminobenzoate, respectively. We found that specific activity of EC 3.4.24.15, defined as activity inhibited with N-[(1RS)-carboxy-3-phenylpropyl]-ala-ala-phe-paraaminobenzoate+ ++, was significantly higher (p < 0.001) in cells from Sprague-Dawley rats (485 +/- 123 nmol/mg protein.hr) than in cells from Hartley guinea pigs (138 +/- 94 nmol/mg protein.hr), healthy human male smokers (121 +/- 73 nmol/mg protein.hr) and healthy human male nonsmokers (94 +/- 12). In contrast, activity of EC 3.4.24.11, defined as activity inhibited with N-[(1RS)-carboxy-3-phenylpropyl]-phe-paraaminobenzoate, was significantly higher (p < 0.001) in cells from human smokers (689 +/- 167 nmol/mg protein.hr) and nonsmokers (762 +/- 136 nmol/mg protein.hr) than in cells from rats (52 +/- 12 nmol/mg protein.hr) and guinea pigs (34 +/- 14 nmol/mg protein.hr). An additional activity in alveolar macrophages toward tertiary butorycarbonyl-phe-ala-ala-phe-paraaminobenzoate was inhibited with L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-guanido) butane, a specific inhibitor of cysteine proteinases, a finding of interest because in general enzymes in this class show little activity at neutral pH.(ABSTRACT TRUNCATED AT 250 WORDS)
中性内肽酶EC 3.4.24.11和EC 3.4.24.15是广泛分布的锌金属内肽酶,可降解多种生物活性肽,包括P物质、缓激肽、神经降压素和促黄体生成素释放激素。在本研究中,我们分别用底物戊二酰-丙氨酰-苯丙氨酰-2-萘胺和叔丁氧羰基-苯丙氨酰-丙氨酰-苯丙氨酰-对氨基苯甲酸酯,测定了肺泡巨噬细胞(肺中的关键炎症细胞,可产生并对包括趋化肽在内的大量生物活性物质作出反应)中的EC 3.4.24.11和EC 3.4.24.15活性。我们发现,EC 3.4.24.15的比活性(定义为被N-[(1RS)-羧基-3-苯丙基]-丙氨酰-丙氨酰-苯丙氨酰-对氨基苯甲酸酯抑制的活性)在来自Sprague-Dawley大鼠的细胞(485±123 nmol/mg蛋白·小时)中显著高于来自Hartley豚鼠的细胞(138±94 nmol/mg蛋白·小时)、健康男性吸烟者的细胞(121±73 nmol/mg蛋白·小时)和健康男性非吸烟者的细胞(94±12)(p<0.001)。相反,EC 3.4.24.11的活性(定义为被N-[(1RS)-羧基-3-苯丙基]-苯丙氨酰-对氨基苯甲酸酯抑制的活性)在吸烟者(689±167 nmol/mg蛋白·小时)和非吸烟者(762±136 nmol/mg蛋白·小时)的细胞中显著高于大鼠(52±12 nmol/mg蛋白·小时)和豚鼠(34±14 nmol/mg蛋白·小时)的细胞(p<0.001)。肺泡巨噬细胞对叔丁氧羰基-苯丙氨酰-丙氨酰-苯丙氨酰-对氨基苯甲酸酯的另一种活性被半胱氨酸蛋白酶的特异性抑制剂L-3-羧基-反式-2,3-环氧丙酰-亮氨酰胺基-(4-胍基)丁烷抑制,这一发现很有意思,因为这类酶通常在中性pH下活性较低。(摘要截断于250字)